Zeugma Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 14 Year, 1 Month
About Zeugma Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Samir Borthakur and Binod Barthakur serve as directors at the Company.
- CIN/LLPIN
U24290AS2010PTC010270
- Company No.
010270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2010
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Sibsagar, Assam, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Zeugma Pharmaceuticals Private Limited offer?
Zeugma Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Lycopene Syrup, Pantoprazole Drugs, Pantoprazole & Domperidone Capsules, Lycopene, Antibiotic Injection, Ceftriaxone Tazobactam Injection, Pantoprazole Tablets, Vitamin & Multivitamin Injections, Methylcobalamin Injection.
Who are the key members and board of directors at Zeugma Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Borthakur  | Director | 11-Nov-2010 | Current |
| Binod Barthakur | Director | 11-Nov-2010 | Current |
Financial Performance of Zeugma Pharmaceuticals.
Enhance accessibility to Zeugma Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Zeugma Pharmaceuticals?
Unlock access to Zeugma Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zeugma Pharmaceuticals?
Unlock and access historical data on people associated with Zeugma Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeugma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeugma Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
